ISB, which targets PKM2 in macrophages, significantly improves cardiac function, reduces myocardial cell apoptosis, and suppresses the inflammation caused by reperfusion, making it a promising new drug for protecting the heart from MI/R injury [71]. The gene discussed is PKM; the disease is myocardial infarction.